September 26, 2022 — Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many cancer types to South Florida communities in need, are for the first time offering prostate-specific antigen (

September 26, 2022 — The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and the ratio of FGV to total breast volume (TGV).

September 21, 2022 — By partnering with Hamamatsu, Infinitt can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review sli

September 21, 2022 — Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care through the power of handheld, whole-body ultrasound a

September 22, 2022 — DenseBreast-info.org (DB-i) announced that it will host the inaugural 

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech company deepc, offering one of the leading 

September 22, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and 

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a new gadolinium-based contrast agent. In consideration of the surge of GBCA use the imaging industry has experienced, as a result of COVID lockdowns in China and related contrast agent shortages that led to conservation strategies, ITN is providing information from both companies involved in this important partnership update.

September 22, 2022 — By partnering with Hamamatsu, Infinitt can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow.

Subscribe Now